Michael A. Berman, Director at CADENCE PHARMACEUTICALS INC (CADX), bought 10,000 shares at $5.15 ($54K) on 2008-03-17, disclosed to the SEC on 2008-03-19.
Open-market purchase of $54k CADX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.90 | 290 | $1K | 2.6% |
| 2 | $5.05 | 1,500 | $8K | 14.1% |
| 3 | $5.15 | 140 | $721 | 1.3% |
| 4 | $5.20 | 800 | $4K | 7.7% |
| 5 | $5.28 | 1,000 | $5K | 9.8% |
| 6 | $5.30 | 1,000 |
| $5K |
| 9.9% |
| 7 | $5.30 | 500 | $3K | 4.9% |
| 8 | $5.36 | 100 | $536 | 1.0% |
| 9 | $5.37 | 400 | $2K | 4.0% |
| 10 | $5.60 | 4,000 | $22K | 41.7% |
| 11 | $5.76 | 270 | $2K | 2.9% |
| Total | $5.37 avg | 10,000 | $54K | 100% |
| Filing → |
| MDC | SELL | 2019-09-17 | $290K | — | Filing → |
| MDC | SELL | 2019-09-16 | $408K | — | Filing → |
| MDC | SELL | 2019-09-12 | $391K | — | Filing → |